These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The expression of hamartin, the product of the TSC1 gene, in normal human tissues and in TSC1- and TSC2-linked angiomyolipomas. Plank TL, Logginidou H, Klein-Szanto A, Henske EP. Mod Pathol; 1999 May; 12(5):539-45. PubMed ID: 10349994 [Abstract] [Full Text] [Related]
8. Morphology of cerebral lesions in the Eker rat model of tuberous sclerosis. Wenzel HJ, Patel LS, Robbins CA, Emmi A, Yeung RS, Schwartzkroin PA. Acta Neuropathol; 2004 Aug; 108(2):97-108. PubMed ID: 15185103 [Abstract] [Full Text] [Related]
12. Mourning Dr. Alfred G. Knudson: the two-hit hypothesis, tumor suppressor genes, and the tuberous sclerosis complex. Hino O, Kobayashi T. Cancer Sci; 2017 Jan; 108(1):5-11. PubMed ID: 27862655 [Abstract] [Full Text] [Related]
13. Comprehensive mutation analysis of TSC1 and TSC2-and phenotypic correlations in 150 families with tuberous sclerosis. Jones AC, Shyamsundar MM, Thomas MW, Maynard J, Idziaszczyk S, Tomkins S, Sampson JR, Cheadle JP. Am J Hum Genet; 1999 May; 64(5):1305-15. PubMed ID: 10205261 [Abstract] [Full Text] [Related]
14. Biallelic TSC gene inactivation in tuberous sclerosis complex. Crino PB, Aronica E, Baltuch G, Nathanson KL. Neurology; 2010 May 25; 74(21):1716-23. PubMed ID: 20498439 [Abstract] [Full Text] [Related]
15. Tsc2 gene inactivation causes a more severe epilepsy phenotype than Tsc1 inactivation in a mouse model of tuberous sclerosis complex. Zeng LH, Rensing NR, Zhang B, Gutmann DH, Gambello MJ, Wong M. Hum Mol Genet; 2011 Feb 01; 20(3):445-54. PubMed ID: 21062901 [Abstract] [Full Text] [Related]
16. Localization of tuberous sclerosis 2 mRNA and its protein product tuberin in normal human brain and in cerebral lesions of patients with tuberous sclerosis. Kerfoot C, Wienecke R, Menchine M, Emelin J, Maize JC, Welsh CT, Norman MG, DeClue JE, Vinters HV. Brain Pathol; 1996 Oct 01; 6(4):367-75. PubMed ID: 8944308 [Abstract] [Full Text] [Related]
17. Tuberin and hamartin are aberrantly expressed and linked to clinical outcome in human breast cancer: the role of promoter methylation of TSC genes. Jiang WG, Sampson J, Martin TA, Lee-Jones L, Watkins G, Douglas-Jones A, Mokbel K, Mansel RE. Eur J Cancer; 2005 Jul 01; 41(11):1628-36. PubMed ID: 15951164 [Abstract] [Full Text] [Related]
18. Simultaneous loss of hamartin and tuberin from the cerebrum, kidney and heart with tuberous sclerosis. Mizuguchi M, Ikeda K, Takashima S. Acta Neuropathol; 2000 May 01; 99(5):503-10. PubMed ID: 10805093 [Abstract] [Full Text] [Related]
19. TSC1 and TSC2 Gene Mutations in Chinese Tuberous Sclerosis Complex Patients Clinically Characterized by Epilepsy. He J, Zhou W, Shi J, Lin J, Zhang B, Sun Z. Genet Test Mol Biomarkers; 2020 Jan 01; 24(1):1-5. PubMed ID: 31855466 [Abstract] [Full Text] [Related]
20. Mutational analysis of TSC1 and TSC2 in Japanese patients with tuberous sclerosis complex revealed higher incidence of TSC1 patients than previously reported. Niida Y, Wakisaka A, Tsuji T, Yamada H, Kuroda M, Mitani Y, Okumura A, Yokoi A. J Hum Genet; 2013 Apr 01; 58(4):216-25. PubMed ID: 23389244 [Abstract] [Full Text] [Related] Page: [Next] [New Search]